5-Aminolaevulinic Acid-Based Photodynamic Therapy Restrains Pathological Hyperplasia of Fibroblasts

Area of Science:

• Dermatology
• Biomedical Engineering
• Cell Biology

Background:

• Hyperplastic scars result from excessive fibroblast proliferation.
• Fibroblast activity significantly contributes to scar pathology.
• Understanding fibroblast regulation is key to scar treatment.

Purpose of the Study:

• To investigate the efficacy of 5-aminolaevulinic acid-based photodynamic therapy (ALA-PDT) in restraining fibroblast hyperplasia in scar tissues.
• To elucidate the underlying mechanisms by which ALA-PDT affects fibroblast behavior and extracellular matrix production.

Main Methods:

• Fibroblasts isolated from hyperplastic scar tissues were treated with ALA-PDT.
• Cell proliferation, cell cycle, and apoptosis were assessed using MTT assay, flow cytometry, and TUNEL assay.
• Co-culture systems were used to evaluate the effect of treated fibroblasts on vascular endothelial cells.
• Gene and protein expression of key fibrotic markers (TGF-β1, α-SMA, Collagen I, Collagen III, VEGFA, bFGF) were analyzed via real-time PCR and Western blot.

Main Results:

• ALA-PDT significantly inhibited fibroblast proliferation and delayed cell cycle progression.
• The therapy induced apoptosis in scar fibroblasts.
• ALA-PDT suppressed the growth-promoting effect of fibroblasts on vascular endothelial cells.
• Expression levels of TGF-β1, α-SMA, Collagen I, Collagen III, VEGFA, and bFGF were decreased following ALA-PDT treatment.

Conclusions:

• ALA-PDT demonstrates significant inhibitory effects on pathological fibroblast hyperplasia in hyperplastic scar tissues.
• The mechanism involves reduced proliferation, induced apoptosis, and suppressed expression of key fibrotic and angiogenic factors.
• ALA-PDT shows promise as a therapeutic strategy for managing hyperplastic scars.